Pravin S, Nanthagopal P, Ayyappan T
Pravin S1*, Nanthagopal P2, Ayyappan T3
1,3 Department of Pharmaceutics, Adhiparasakthi College of Pharmacy, Melmaruvathur, Tamil Nadu, 603319, India.
2Department of Pharmaceutical Chemistry, Adhiparasakthi College of Pharmacy, Melmaruvathur, Tamil Nadu, 603319, India.
*Corresponding Author E-mail:
Volume - 15,
Issue - 11,
Year - 2022
Dengue is endemic in more than 100 countries and it is estimated that annually above 390 million infections occur globally. During the period between 1996-2015, a massive increase of more than 500 percent has been recorded in number of dengue cases reported in India. Dengue is a disease caused by any one of four closely related viruses (DEN-1, DEN-2, DEN-3, or DEN-4). The viruses are transmitted to humans by the bite of an infected mosquito (Aedes aegypti). The Aedes aegypti mosquito is the vector of dengue/dengue hemorrhagic fever. Dengue Hemorrhagic Fever is a more severe form of dengue. There is no specific medication for treatment of a dengue infection. In India mostly herbal products are majorly used for many treatments. The development of polyherbal formulation for Dengue Fever in the form of tablets was performed in this present study. The polyherbal tablets were prepared by using herbals like Andrographis paniculata Nees, Carica papaya Linn and Ocimum sanctum Linn leafs with excipients like Lactose Monohydrate, Microcrystalline Cellulose, Cross Povidone, Colloidal Silicon Dioxide, Methyl Paraben and Magnesium Stearate for the treatment of dengue fever. The plants are collected and plants materials was identified and authenticated taxonomically. The presence of active constituents in herbals was confirmed by preliminary phytochemical screening tests. The preformulation studies were carried out for the powder blends; it was evaluated to determine the bulk density, tapped density and the flow characteristics by angle of repose, carr’s index and hausner’s ratio. The data obtained from these studies indicated that the powder blends have good flow properties. The tablets were prepared with powdered herbals leafs and different ratios of excipients by direct compression. The formulated tablets were evaluated for physical characterization like appearance, weight variation, thickness, hardness, friability, and disintegration. Evaluation studies of all formulations shows that the weight variation, friability and disintegration complies with specification. The disintegration study of formulation F3 was concluded the best formulation among other formulation, which shows the faster disintegration. So, formulation F3 was considered as optimized formulation. Finally, among the three formulations, the formulation F3 showed better results than other formulations in respect of evaluation parameters.
Cite this article:
Pravin S, Nanthagopal P, Ayyappan T. Development and Evaluation of Polyherbal Formulation for the treatment of Dengue Fever. Research Journal of Pharmacy and Technology. 2022; 15(11):4981-6. doi: 10.52711/0974-360X.2022.00837
Pravin S, Nanthagopal P, Ayyappan T. Development and Evaluation of Polyherbal Formulation for the treatment of Dengue Fever. Research Journal of Pharmacy and Technology. 2022; 15(11):4981-6. doi: 10.52711/0974-360X.2022.00837 Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-11-22
1. Singh PK, Rawat P. Evolving herbal formulations in management of dengue fever. Journal of Ayurveda and Integrative Medicine. 2017 Jul-Sep;8(3):207-210. doi: 10.1016/j.jaim.2017.06.005.
2. Anonymous. Dengue. Health & Family Welfare Department, Government of Tamil Nadu. https://tnhealth.tn.gov.in/tngovin/dph/dphdbdengue.php
3. Mukhopadhyay S, Kuhn, R. J. & Rossmann, M. G. A structural perspective of the flavivirus life cycle. Nature Reviews Microbiology, 2005;3(1):13–22. doi:10.1038/nrmicro1067
4. Duane j. Gubler. Dengue and Dengue Hemorrhagic Fever.Clinical Microbiology Reviews. 1998 Jul;11(3):480–496.
5. Panraksa P, Ramphan S, Khongwichit S, Smith DR. Activity of andrographolide against dengue virus. Antiviral Research. 2017 Mar;139:69-78. doi: 10.1016/j.antiviral.2016.12.014.
6. Aziz J, Abu Kassim N. L, Abu Kasim N. H, Haque N. & Rahman, M. T. Carica papaya induces in vitro thrombopoietic cytokines secretion by mesenchymal stem cells and haematopoietic cells. BMC Complementary and Alternative Medicine, 2015; 15(1):215. doi:10.1186/s12906-015-0749-6.
7. Halim S, Abdullah R, Afzan A, Abdul R, Jantan I, Ismail Z .Acute toxicity study of Carica papaya Linn leaf extract in Sprague Dawley rats. J. Med. Plants Res. 2011;5:1867-1872.
8. Cohen MM. Tulsi - Ocimum sanctum: A herb for all reasons. Journal of Ayurveda and Integrative Medicine, 2014;5(4) :251-259.
9. C.K Kokate, A.P Purohit, S.B Gokhale. Pharmacognosy. Nirali Prakashan, Pune. 2015; 51thedn: A.22 - A.27.
10. Anonymous. Indian Pharmacopoeia. The Indian Pharmacopoeia Commission, Ghaziabad. 2014;7th edn,Vol-Ι:162-163.
11. Subrahmanyam C.V.S. Textbook of Physical Pharmaceutics. Vallabh Prakashan, New Delhi. 2015;3rdedn:251-267.
12. S. J. Daharwal, S Prakash Rao, Vijay Kumar Singh, Kunal Chandrakar, Veena D. Singh. Formulation and Characterization of Metformin HCl Sustained Release Matrix Tablet by using Cassia tora Mucilage. Research J. Pharm. and Tech. 2015 July;8(7): 871-879.
13. Kanhu Charan Panda, Niranjan Panda, Chinmaya Keshari Sahoo, Jimidi Bhaskar , D. Venkata Ramana. Formulation and Evaluation of Immediate release tablets of Topiramate using Sodium starch glycolate. Research J. Pharm. and Tech. 2019; 12(6): 3024-3028.
14. SH Lakade, MR Bhalekar. Formulation and Evaluation of Sustained Release Matrix Tablet of Anti-Anginal Drug, Influence of Combination of Hydrophobic and Hydrophlic Matrix Former. Research J. Pharm. and Tech. 2008 Oct.-Dec;1(4): 410-413.
15. Rajalakshmi G, Kanchalochanaa S.N, Joshny J, Vedha Hari B.N, Ramya Devi D. Formulation of Pushyanuga churna Polyherbal Tablets Using Tamarind Seed Polysaccharide. Research J. Pharm. and Tech. 2012 Sep;5(9):1204-1208.
16. Deepika, Amit Alexander, Palak Agrawal, Tripti Banjare, Aditi Bhatt, Swapnil Gupta, Akansha Bhandarkar, Hemlata Sahu, Shradha Devi Diwedi, Siddharth Kumar Sahu, Pooja Yadav, Kailash Sahu, Deeksha Dewangan, Hemlata Thapa, Pankaj Sahu, Sonam Soni, Ajay Singh, Mukesh Sharma, D. K. Tripathi, Ajazuddin. Formulation and Evaluation of immediate release tablet of Risperidone. Research J. Pharm. and Tech. 2018;11(6):2301-2305.
17. Avinash Bhagwat, Suhas M Kakade, Chirag V Naval, Mukesh Tilker, Ravindra M Walture, Sagar A Adichwal and Atul P Chaudhari. Formulation and Evaluation of Mouth Dissolving Tablets of Domperidone. Research J. Pharm. and Tech. July-Sept. 2010; 3 (3):821-824.
18. Palak Agrawal, Ajazuddin, Tripti Banjare, Swapnil Gupta, Akansha Bhandarkar, Hemlata Sahu, Shradha Devi Diwedi, Pankaj Sahu, Siddharth Kumar Sahu, Pooja Yadav, Aditi Bhatt, Kailash Sahu, Deeksha Dewangan, Hemlata Thapa, Deepika, Gyanesh Sahu, Mukesh Sharma, D. K. Tripathi, Amit Alexander. Formulation and Evaluation of directly compressed Floating Tablets of Candesartan Cilexetil for Gastro Retentive Drug Delivery. Research J. Pharm. and Tech. 2018;11(7):2804-2808.
19. Shinde Sunita S, Amol S. Shete, Patil Manisha V, J.I. Disouza. Formulation and Evaluation of Sustained Release Tablets using Direct Compression Method. Research J. Pharm. and Tech. June 2013;6(6):637-640.
20. Mahale AM, Sakarkar DM, Wanare RS, Masirkar VJ, Mantri RH, Tayade AM, Jadhav JK. Formulation and Evaluation of Directly Compressible Dispersible Tablets of Hingashtak churna. Research J. Pharm. and Tech. 2010 Oct-Dec;3(4):1288-1290.
21. Sunirmal Bhattacharjee, Nilayan Guha, Gouranga Dutta, Manas Chakraborty, Mayukh Jana, Susanta Paul. Formulation and Evaluation of Sustained Release Matrix Tablet of Anti-Amoebic Drug by Natural Polymers. Research J. Pharm. and Tech. 2017;10(7):2041-2046.
22. Bibaswan Mishra, Biswaranjan Mohanty, Chandra Sekhar Barik. Formulation Development and Evaluation of Direct compressed Cefpodoxime proxetil Effervescent Tablets. Research J. Pharm. and Tech. 2019;12(6):2695-2699.
23. Aarti P. Nikam, Mukesh. P. Ratnaparkhi. Formulation and Evaluation of Losartan Potassium Sustained Release tablets. Research J. Pharm. and Tech. 2014 Nov;7(11):1219-1225.
24. Mahesh PG, Raman S.G. Formulation and Evaluation of Oral Dispersion Tablet of Telmisartan. Research J. Pharm. and Tech. 2020;13(7):3184-3186.
25. Pavani M, D.P. Mastan Yadav, Manikanta Kumar A, K.S. Manjunath Shetty. Formulation and In-Vitro Evaluation of Simvastatin Floating Tablets by Direct Compression Method. Research J. Pharm. and Tech. 2013 Dec;6(12):1468-1471.
26. Abdul Sayeed, Hamed M, Mohd Rafiq. Formulation and In vitro Evaluation of Mouth Dissolving Tablets of Carvedilol by Direct Compression Methods. Research J. Pharm. and Tech. 2012 Dec;5(12):1525-1531.
27. N. Sravanthi, Alekhya, I. Vikram Reddy. Formulation and Evaluation of Mouth Dissolving Tablets of Clozapine by Direct Compression Method. Research J. Pharm. and Tech. 2017;10(8):2543-2550.
28. Lachman L, Lieberman H. The Theory and Practice of Industrial Pharmacy. CBS Publisher & Distributer, New Delhi. 2013; 4th edn:479-491.
29. Subhendu Mishra, Prashant Y Mali, Asha Kesri, Asit Sahu, Bibhu Mishra, Bhupendra Behera. Formulation and In-Vitro Evaluation of Fast Dissolving Tablets of Paracetamol by Direct Compression Technique. Research J. Pharm. and Tech. July-Sept. 2010;3 (3):934-937.
30. Dhruv Patel, Upendra Patel, Maitri Shukla, Bhavin Bhimani, Ghanshyam Patel. Formulation and Evaluation of Immediate Release Tablet of Simvastatin. Research J. Pharm. and Tech. 2020;13(1):421-224.
31. Pawan Singh, Prevesh Kumar, Neelkant Prasad. Formulation and Evaluation of Aspirin Tablets by Using Different Lubricants in Combination for better Kinetic Drug Release Study by PCP. Research J. Pharm. and Tech. 2017;10(9):2934-2938 .
32. Mujeeb Patwegar, Rohit R. Shah. Formulation and Evaluation of Sustained Release Tablet of Torsemide. Research J. Pharm. and Tech 2018;11(11):4924-4928.